James Cancer Institute at Ohio State University is conducting a major study of ellagic acid.

For further information: http://www.ag.ohio-state.edu/~sfgnet/ellagic.html

The Hollings Cancer Institute at the University of South Carolina is conducting a double blind study on 500 cervical cancer patients.

Their previous nine years of study has shown that ellagic acid is causing G-arrest (inhibiting and stopping mitosis-cancer cell division) within 48 hours, and apoptosis (cell death) within 72 hours. This includes cancer of the breast, pancreas, esophagus, skin, colon, and prostate.

Other Studies come from:

College of Medicine, University of Illinois

Northwestern University School of Medicine

Department of Preventive Medicine, Ohio State University